Tinabinol (INN: SP-119) is a synthetic cannabinoid drug and analogue of dronabinol (Δ9-tetrahydrocannabinol) and dimethylheptylpyran which was patented as an antihypertensive but was never marketed.[1][2]
Clinical data | |
---|---|
Drug class | Cannabinoid |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H34O2S |
Molar mass | 374.58 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Brown DT (19 November 1998). Cannabis: The Genus Cannabis. CRC Press. p. 80. ISBN 978-90-5702-291-3. Retrieved 27 April 2012.
- ^ Negwer M (1994). Organic-chemical drugs and their synonyms: an international survey. Indices. Akad.-Verl. p. 2242. ISBN 978-3-05-501629-5. Retrieved 27 April 2012.